BioSpace News Archive

Phase 2 Trial with Bavituximab in Patients with Gastric Cancer on Track to Report Preliminary Results During the Second Half of 2020

The World Economic Forum announced its selection of 100 of the most promising Technology Pioneers of 2020, which are shaping industries from agriculture to healthcare while also working on sustainability issues and much more.

Bristol-Myers Squibb Company (NYSE:BMY) (“ Bristol Myers Squibb ”) announced today the commencement of its offers to exchange (the “ Registered Exchange Offers ”) any and all of its outstanding (i) $19,000,000,000 aggregate principal amount of senior unsecured notes previously issued on May 16, 2019 (“ May Notes ”) pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (the

Schrödinger (Nasdaq: SDGR), whose physics-based software platform enables discovery of high-quality, novel molecules for therapeutics and materials, today announced that members of the management team will participate in a fireside chat at the BMO 2020 Prescriptions for Success Healthcare Conference at 2:30 p.m. ET on Tuesday, June 23, 2020. A live webcast of the presentation can be accessed under “News & Events” in th

Proceeds will be used to advance 4DMT’s three precision-guided AAV gene therapy candidates through initial clinical proof-of-concept, to advance pre-clinical product pipeline and proprietary next-generation Therapeutic Vector Evolution platform, and to expand internal GMP manufacturing capabilities – 4D-310 for the treatment of Fabry Disease, 4D-125 for the treatment of XLRP and 4D-110 for the treatment of choroideremia are each expected to enter the

Spectrum Pharmaceuticals to Present Preclinical ROLONTIS ® (eflapegrastim) Same Day Dosing Data at AACR Virtual Annual Meeting II

Growing prevalence of ophthalmic disorders such as glaucoma, age-related macular degeneration, cataract, diabetic retinopathy, refractive disorders, retinal disorders, and cataract is anticipated to drive excimer and femtosecond ophthalmic lasers market.

The growth of the medical and healthcare research industries has given an impetus to the growth of the global medical nutrition market.

Annovis Bio Inc., a clinical-stage drug platform company addressing Alzheimer’s disease, Parkinson’s disease and other neurodegenerative diseases, announced it successfully completed the rat cohort of a chronic toxicology study of its lead therapeutic compound ANVS401, reporting no negative side effects.

Nemaura Medical, Inc. announced Fred Schaebsdau, MD, PhD, Vice President of Strategy and Strategic Alliances, took part as guest speaker at the DiabetesMine™ D-Data Virtual ExChange held on June 12, 2020.